Senior Director, Data Strategy & Solutions

Vertex Pharmaceuticals

Alex Aronov is Senior Director and Head of Data Science at Vertex Pharmaceuticals, a function he co-founded in 2017 to address data-centric problems across the entire business through application of advanced analytics and machine learning.

Previously, Alex led the Discovery Informatics team at Vertex, with responsibility for the high throughput screening content and enrichment, the global chemical genomics initiative, as well as the company’s toxicogenomics efforts. From 2007 to 2012, he led a cross-functional team from lead discovery to late preclinical development that delivered a novel immuno-oncology candidate BVD-723. Alex started his career at Vertex as a computer-aided drug design scientist in 2001, and was involved in projects across a range of therapeutic areas from oncology to inflammation, and from rare diseases to antivirals.

He serves on the Drug Discovery for the Nervous System committee at the Center for Scientific Review/NIH, and is a board member for MIT delta v entrepreneurship bootcamp at the MIT Martin Trust Center.

Alex is an author of over 30 peer-reviewed manuscripts, and is an inventor on over 40 international patent applications. He holds a PhD in chemistry from the University of Washington, and completed postdoctoral training at the University of California, San Francisco School of Pharmacy. He received an MBA from MIT Sloan School of Management.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement